Sponsored Content
Intercell Still Reports Losses
The Austrian pharmaceutical company could reduce its net losses from € 50.8m to € 20.62m. For the full year the net loss expectations ranges up to € 40m.
Intercell Still Reports Losses / Picture: © Intercell
In spite of drastic losses, Intercell is optimistic and announces to have absolved the restructuring process. Nevertheless, losses and cash flow figures could improve.
In the first nine months of 2011, revenues were up by 22.7%. Sales grew from € 21.1m to € 25.9m. In the third quarter, revenues grew from € 6.70m to € 7.52m.
Net losses for the first nine months…
or Log In
Fast News Search